A carregar...

COVID-19 antibodies on trial

With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Biotechnol
Autor principal: DeFrancesco, Laura
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group US 2020
Assuntos:
Q&A
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576980/
https://ncbi.nlm.nih.gov/pubmed/33087898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41587-020-0732-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!